PROMIS NEUROSCIENCES INC. Deferred Tax Assets, Investments
PROMIS NEUROSCIENCES INC. (PMN) had Deferred Tax Assets, Investments of $1.94 million as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInvestments · last filed 2026-03-25
- 2025-12-31: Deferred Tax Assets, Investments $1.94M.
- 2024-12-31: Deferred Tax Assets, Investments $2.04M.
- 2023-12-31: Deferred Tax Assets, Investments $2.09M.
- 2022-12-31: Deferred Tax Assets, Investments $2.15M.
| Period end | Deferred Tax Assets, Investments |
|---|---|
| 2025-12-31 | $1.94M 10-K · filed 2026-03-25 |
| 2024-12-31 | $2.04M 10-K · filed 2026-03-25 |
| 2023-12-31 | $2.09M 10-K · filed 2025-03-31 |
| 2022-12-31 | $2.15M 10-K · filed 2024-04-01 |
| 2021-12-31 | $2.20M 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |